delayed preputial separation in rats does not necessarily indicate antiandrogenicity—evaluation of...

1
Abstracts / Toxicology Letters 196S (2010) S37–S351 S191 developing fetuses and breast-fed infants are the most highly exposed population groups. This study investigated the impacts of perinatal exposure to low doses of a chemical mixture (polychlorinated biphenyls, organochlorine pesticides and methylmercury) present in the blood of the arctic Inuit population on the retinoid system and other endpoints, including body and organ weights and enzyme induc- tion, in rat dams and their offspring. Pregnant Sprague–Dawley rats were given the reconstituted mixture (0, 0.05, 0.5 and 5 mg/kg bw/day) from gestational day 1 through weaning. One male and one female offspring were sacrificed at postnatal days (PNDs) 35, 77 and 350 and the dams at 7–10 days after weaning. Frozen samples of liver and kidney were kept for subsequent analyses. Following high dose treatment; hepatic retinoids were decreased in both sexes of the offspring at PNDs 35, 77 and 350, as well as in the dams, while the renal retinoids were increased in both sexes of the offspring but decreased in the dams. Also, body, liver and kidney weights were decreased in the high-dose groups of both sexes of offspring. The effects in the treated offspring were less evident at PND350 than at PNDs 35 and 77, likely due to the dis- continued exposure after weaning. Critical effect doses (CEDs) for hepatic retinyl palmitate modulation (5%) ranged between 0.41 and 0.09 mg/kg bw/day at PNDs 35 and 77 respectively; whereas CED for renal retinyl palmitate modulation (5%) at PND 77 was 0.36 mg/kg bw/day. Maximum responses ranged from 21% to 75% for hep- atic retinoids. Renal retinyl palmitate showed a maximum response of +97%. CEDs (100%) for hepatic and renal P450 enzyme induc- tion in the offspring at PND35 ranged between 0.42 and 2.87 mg/kg bw/day respectively. doi:10.1016/j.toxlet.2010.03.648 P204-025 Delayed preputial separation in rats does not necessarily indicate antiandrogenicity—Evaluation of 2-generation toxicity studies of chemicals and agro-chemicals S. Melching-Kollmuss, K. Hempel, R. Buesen, I. Fegert, S. Schneider, B. Van Ravenzwaay BASF SE, Germany Endocrine disrupters are under special focus of authorities. While parameters assessing potentially endocrine related effects are investigated in both screening and regulatory toxicity studies of chemicals and agro-chemicals, no clear guidance is given which data provide definitive proof if a substance is an endocrine dis- ruptor causing adverse effects. One of the parameters considered to be able to detect antiandrogenicity in rats is the onset of male puberty, determined by the age of animals at preputial separation. This parameter amongst others has therefore been included in the past into the regulatory guidelines for studies evaluating repro- ductive toxicity and offspring development (i.e. OPPTS 870.3800 a; OECD 416). Several factors have been discussed by different authors to influence the onset of puberty: feed restriction, decreased mater- nal/offspring body weight development, leptin levels, or intensive handling. Since the guidelines require setting the high dose at a level where significant signs of toxicity are seen, changes on food con- sumption or body weight development are commonly seen in regulatory toxicity studies. Thus, we have evaluated the poten- tial relationship between the onsets of puberty in male animals with parameters of maternal/offspring food consumption and body weight changes in several 2-generation toxicity studies in rats per- formed over the last 10 years in our laboratory with chemicals or agro-chemical. Onset of male puberty in control animals var- ied from day 40 to 47, with a median at day 42, the body weights of our rat strain at day of preputial separation was in the range of 142–215 g (median value: 174 g). A comparison with the dosed groups revealed that the age of animals at the onset of puberty in male rats was correlated with maternal and/or offspring body weight development. In conclusion, the isolated finding of delayed preputial separation is not sufficient to prove an antiandrogenic mode of action. doi:10.1016/j.toxlet.2010.03.649 P204-026 Maternal and developmental toxicity study of tetrodotoxin in rats A. Guzmán 1 , A. Ho 2 , P. Ruth 3 , A. Tortajada 1 , A.R. Fernández De Henestrosaa 1 , P. Thirlwell 3 , C. García 1 , M.T. Ruiz 1 , A.P. Marín 1 1 Esteve, United States, 2 WEX Pharmaceuticals Inc., United States, 3 Huntingdon Life Sciences, United Kingdom The naturally occurring neurotoxin tetrodotoxin (TTX; octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano- 10aH-(1,3)dioxocino(6,5 d)pyrimidine-4,7,10,11,12-pentol) is among the most deadly poisons known to man. TTX has sodium channel blocking activity and shows analgesic activity in animal pain models suggesting a possible use for TTX as an analgesic for the treatment of human pain conditions. The maternal and develop- mental toxicity of TTX was assessed in pregnant Sprague–Dawley rats (22 dams/group) following daily subcutaneous administration of its injectable dose form (supplied by WEX Pharmaceuticals) during Days 6–17 of gestation at doses of 2, 4 or 8 g/kg/day. Animals were killed on Day 20 of gestation and subjected to a full macroscopic examination. Uterine contents were examined and the numbers of corpora lutea, implantation sites, early and late resorptions, and live/dead fetuses recorded. Approximately half of each litter were eviscerated and processed for skeletal examination, and the remaining fetuses were fixed in Bouin’s fluid for internal examination by free-hand serial sectioning. There were no maternal deaths related to treatment with TTX. Signs of underactive behaviour and partially closed eyelids were observed at 4 and 8 g/kg/day, with abnormal gait at 8 g/kg/day. During treatment bodyweight gain was low at all dose levels (although at 2 g/kg/day the effect was transient) and food consumption was low at 4 and 8 g/kg/day. Embryo-fetal survival was not affected by treatment. Fetal weights were low at 4 and 8 g/kg/day, and placental weights were low at 8 g/kg/day. A slightly high inci- dence of fetuses/litters with hepatic haemorrhages and incomplete ossification/unossified sternebrae was observed at 8 g/kg/day. These findings were considered to reflect a delay in fetal matu- ration consequent to maternal toxicity. At 2 or 4 g/kg/day there were no fetal abnormalities that could be related to maternal treatment. The NOAELs for maternal and developmental toxicity were 2 and 4 g/kg/day, respectively. doi:10.1016/j.toxlet.2010.03.650

Upload: s-melching-kollmuss

Post on 29-Oct-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

etters

de

tobetrbf3l

dablolch0rbaotb

d

PDit

SS

EpicdrtpTpdOtnh

wsrtwwf

were no fetal abnormalities that could be related to maternaltreatment. The NOAELs for maternal and developmental toxicitywere 2 and 4 �g/kg/day, respectively.

doi:10.1016/j.toxlet.2010.03.650

Abstracts / Toxicology L

eveloping fetuses and breast-fed infants are the most highlyxposed population groups.

This study investigated the impacts of perinatal exposureo low doses of a chemical mixture (polychlorinated biphenyls,rganochlorine pesticides and methylmercury) present in thelood of the arctic Inuit population on the retinoid system and otherndpoints, including body and organ weights and enzyme induc-ion, in rat dams and their offspring. Pregnant Sprague–Dawleyats were given the reconstituted mixture (0, 0.05, 0.5 and 5 mg/kgw/day) from gestational day 1 through weaning. One male and oneemale offspring were sacrificed at postnatal days (PNDs) 35, 77 and50 and the dams at 7–10 days after weaning. Frozen samples of

iver and kidney were kept for subsequent analyses.Following high dose treatment; hepatic retinoids were

ecreased in both sexes of the offspring at PNDs 35, 77 and 350,s well as in the dams, while the renal retinoids were increased inoth sexes of the offspring but decreased in the dams. Also, body,

iver and kidney weights were decreased in the high-dose groupsf both sexes of offspring. The effects in the treated offspring wereess evident at PND350 than at PNDs 35 and 77, likely due to the dis-ontinued exposure after weaning. Critical effect doses (CEDs) forepatic retinyl palmitate modulation (5%) ranged between 0.41 and.09 mg/kg bw/day at PNDs 35 and 77 respectively; whereas CED forenal retinyl palmitate modulation (5%) at PND 77 was 0.36 mg/kgw/day. Maximum responses ranged from −21% to −75% for hep-tic retinoids. Renal retinyl palmitate showed a maximum responsef +97%. CEDs (100%) for hepatic and renal P450 enzyme induc-ion in the offspring at PND35 ranged between 0.42 and 2.87 mg/kgw/day respectively.

oi:10.1016/j.toxlet.2010.03.648

204-025elayed preputial separation in rats does not necessarily

ndicate antiandrogenicity—Evaluation of 2-generationoxicity studies of chemicals and agro-chemicals

. Melching-Kollmuss, K. Hempel, R. Buesen, I. Fegert, S.chneider, B. Van Ravenzwaay

BASF SE, Germany

ndocrine disrupters are under special focus of authorities. Whilearameters assessing potentially endocrine related effects are

nvestigated in both screening and regulatory toxicity studies ofhemicals and agro-chemicals, no clear guidance is given whichata provide definitive proof if a substance is an endocrine dis-uptor causing adverse effects. One of the parameters consideredo be able to detect antiandrogenicity in rats is the onset of maleuberty, determined by the age of animals at preputial separation.his parameter amongst others has therefore been included in theast into the regulatory guidelines for studies evaluating repro-uctive toxicity and offspring development (i.e. OPPTS 870.3800 a;ECD 416). Several factors have been discussed by different authors

o influence the onset of puberty: feed restriction, decreased mater-al/offspring body weight development, leptin levels, or intensiveandling.

Since the guidelines require setting the high dose at a levelhere significant signs of toxicity are seen, changes on food con-

umption or body weight development are commonly seen inegulatory toxicity studies. Thus, we have evaluated the poten-

ial relationship between the onsets of puberty in male animalsith parameters of maternal/offspring food consumption and bodyeight changes in several 2-generation toxicity studies in rats per-

ormed over the last 10 years in our laboratory with chemicals

196S (2010) S37–S351 S191

or agro-chemical. Onset of male puberty in control animals var-ied from day 40 to 47, with a median at day 42, the body weightsof our rat strain at day of preputial separation was in the rangeof 142–215 g (median value: 174 g). A comparison with the dosedgroups revealed that the age of animals at the onset of pubertyin male rats was correlated with maternal and/or offspring bodyweight development. In conclusion, the isolated finding of delayedpreputial separation is not sufficient to prove an antiandrogenicmode of action.

doi:10.1016/j.toxlet.2010.03.649

P204-026Maternal and developmental toxicity study of tetrodotoxin inrats

A. Guzmán 1, A. Ho 2, P. Ruth 3, A. Tortajada 1, A.R. Fernández DeHenestrosaa 1, P. Thirlwell 3, C. García 1, M.T. Ruiz 1, A.P. Marín 1

1 Esteve, United States, 2 WEX Pharmaceuticals Inc., United States,3 Huntingdon Life Sciences, United Kingdom

The naturally occurring neurotoxin tetrodotoxin (TTX;octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10aH-(1,3)dioxocino(6,5 d)pyrimidine-4,7,10,11,12-pentol) isamong the most deadly poisons known to man. TTX has sodiumchannel blocking activity and shows analgesic activity in animalpain models suggesting a possible use for TTX as an analgesic for thetreatment of human pain conditions. The maternal and develop-mental toxicity of TTX was assessed in pregnant Sprague–Dawleyrats (22 dams/group) following daily subcutaneous administrationof its injectable dose form (supplied by WEX Pharmaceuticals)during Days 6–17 of gestation at doses of 2, 4 or 8 �g/kg/day.Animals were killed on Day 20 of gestation and subjected to afull macroscopic examination. Uterine contents were examinedand the numbers of corpora lutea, implantation sites, early andlate resorptions, and live/dead fetuses recorded. Approximatelyhalf of each litter were eviscerated and processed for skeletalexamination, and the remaining fetuses were fixed in Bouin’s fluidfor internal examination by free-hand serial sectioning. Therewere no maternal deaths related to treatment with TTX. Signs ofunderactive behaviour and partially closed eyelids were observedat 4 and 8 �g/kg/day, with abnormal gait at 8 �g/kg/day. Duringtreatment bodyweight gain was low at all dose levels (although at2 �g/kg/day the effect was transient) and food consumption waslow at 4 and 8 �g/kg/day. Embryo-fetal survival was not affectedby treatment. Fetal weights were low at 4 and 8 �g/kg/day, andplacental weights were low at 8 �g/kg/day. A slightly high inci-dence of fetuses/litters with hepatic haemorrhages and incompleteossification/unossified sternebrae was observed at 8 �g/kg/day.These findings were considered to reflect a delay in fetal matu-ration consequent to maternal toxicity. At 2 or 4 �g/kg/day there